ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2022

Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study.

Satoshi Yoshiji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.